[{"id":"e9c4d110-03d5-44dd-a3c8-1f485f257822","acronym":"","url":"https://clinicaltrials.gov/study/NCT04432649","created_at":"2021-01-18T21:20:46.146Z","updated_at":"2024-07-02T16:36:44.169Z","phase":"Phase 1/2","brief_title":"Targeting CD276 (B7-H3) Positive Solid Tumors by 4SCAR-276","source_id_and_acronym":"NCT04432649","lead_sponsor":"Shenzhen Geno-Immune Medical Institute","biomarkers":" CD276","pipe":"","alterations":" ","tags":["CD276"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e 4SCAR-276"],"overall_status":"Recruiting","enrollment":" Enrollment 100","initiation":"Initiation: 06/01/2020","start_date":" 06/01/2020","primary_txt":" Primary completion: 05/31/2023","primary_completion_date":" 05/31/2023","study_txt":" Completion: 05/31/2024","study_completion_date":" 05/31/2024","last_update_posted":"2020-06-16"}]